Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03126305 · ClinicalTrials.gov registry record
Initial Development and Dissemination of OC-Go
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 8
- Enrollment target
NCT03126305: Completed study, sponsored by University of California, Los Angeles.
NCT03126305 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03126305 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pediatric OCD treatment programs in the UCLA Division of Child and Adolescent Psychiatry
Primary Outcome
10-item self-report measure assessing the usability of the OC-Go application
Interventions
- OTHER OC-Go
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-04-30 |
What the finished NCT03126305 record still lists
NCT03126305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which OC-Go is the first listed.
NCT03126305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03126305 about?
NCT03126305 is a clinical study titled "Initial Development and Dissemination of OC-Go". The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pe...
What is the current status of trial NCT03126305?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2017-05-01. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03126305?
The interventions under investigation include: OC-Go (OTHER).
Who is sponsoring clinical trial NCT03126305?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI